Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-04

Clinical Trial Update: Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study [Phase 3]

View source ↗

Summary

Phase 3 extension study (FAME Extension) evaluating fluocinolone acetonide for diabetic macular edema has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluocinolone acetonide (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2015-05-04